The efficacy and safety of irinotecan and cisplatin as neoadjuvant chemotherapy for cervical cancer
10.3760/cma.j.issn.1008-1372.2016.04.018
- VernacularTitle:伊立替康联合顺铂新辅助化疗对Ⅰ B2～ ⅡB期宫颈癌的有效性和安全性分析
- Author:
Jinwen JIAO
;
Xinwei ZHAO
;
Yuchao DIAO
;
Lei WANG
;
Kejuan SONG
;
Shuzhen DAI
;
Qin YAO
- Publication Type:Journal Article
- Keywords:
Camptothecin/AA/AD;
Cisplatin/AD;
Chemotherapy,adjuvant;
Uterine cervical neoplasms/DT
- From:
Journal of Chinese Physician
2016;18(4):552-556
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy and safety of irinotecan as neoadjuvant chemotherapy (INAC) plus radical surgery (RS) for cervical cancer.Methods According to International Federation of Gynecology and Obstetrics (FIGO),81 cases were divided into Ⅱ B,ⅡA,and Ⅰ B2 groups.According to the tests of UGT1A1 gene polymorphisms,we adjusted the injection dose of irinotecan.The parameters were analyzed,including the efficacy,operation time and bleeding volume,postoperative pathology,survival time,and adverse reactions.The articles on irinotecan or paclitaxel combined with cisplatin for neoadjuvant chemotherapy between 2005 and 2015 were collected,and compared.Results The effective rate of chemotherapy was 81.5％ (Ⅰ B2 group:85.7％;Ⅱ A group:83.3％;and ⅡB group:72.2％),operation time was (5.3 ± 1.1) h,and blood loss was (781 ± 361.7) ml.After chemotherapy,37 cases were delayed diarrhea,70 cases were nausea,48 cases were vomiting,and 40 cases were bone marrow suppression.The infiltration rate,operation time,and blood loss on Ⅱ B group was significantly higher than that on Ⅱ A and Ⅰ B2 groups(P ＜ 0.05),and there was no significant difference in the chemotherapy efficiency,invasion depth,lymphatic metastasis,survival time and adverse reactions(P ＞0.05).Compared to three articles,the total effective rate in this study was higher than that in previous studies,also in Ⅱ A and Ⅱ B group.Conclusions Irinotecan chemotherapy regimens combined with cisplatin is effective and well tolerated.It is worthy of popularization and application.Detection of UGT1A1 gene polymorphism has guiding significance for chemotherapy regimen on irinotecan combined with cisplatin.
